Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Anna and her team wins the Teamwork award for their work on improving the outcome of children with blood diseases in sub-Saharan Africa

Professor Anna Schuh with scientist in Tanzania

 

Professor Anna Schuh and her team have been announced as the Winners of the Teamwork category in the Vice-Chancellor Innovation Awards 2020 for their work on SEREN: A Social Enterprise to deliver DNA-based diagnostics that improves outcomes of children and young adults with blood diseases in sub-Saharan Africa.

The Vice-Chancellor Innovation Awards celebrate research-led innovation that is having societal or economic impact. Building on the awards two years ago a new category of Policy Engagement has been added to those for Teamwork, Building Capacity, Inspiring Leadership, and Early Career Innovator.

Winners and Highly Commended entries were selected by the Vice-Chancellor’s Innovation Awards panel chaired by Professor Chas Bountra, Pro-Vice-Chancellor for Innovation, and comprising academics from each of the four Divisions and Professional Services staff who support impact and innovation across the collegiate University

You can find out more about the Awards and all of 2020’s Winners and Highly Commended entries on the Vice-Chancellor’s Innovation Awards pages.

 Vice-Chancellor Awards logo

 

Similar Stories

First patient diagnosed earlier using liquid biopsy technology as part of the AI-REAL programme in sub-Saharan Africa

The AI-REAL programme led by Professor Anna Schuh and research teams in Tanzania and Uganda is improving the early detection and outcomes of childhood lymphoma in the region by increasing the speed and precision of diagnosis.

Oxford Cancer researchers elected to the European Molecular Biology Organization

Congratulations to Ivan Ahel, Adrian Hill and Yang Shi on their election to the membership of the European Molecular Biology Organization (EMBO)

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.